Site search

Prurigo Nodularis trial Research study

The Prurigo Nodularis trial aims to assess the safety and effectiveness of a treatment to assist in reducing symptoms for people living with this condition

HREC meeting dates and deadlines

The Office for Research has monthly deadlines for submission of new research project applications for review by the RMH Human Research Ethics Committee (HREC).

Treatment & vaccination for tuberculosis

Tuberculosis (TB) disease can be treated with antibiotics. Prevention can involve vaccination, screening, contact tracing and education.

Clinical trial phases

Clinical trials for medication, treatment and devices are divided into phases.

Vertigo drug trial helping patients with ‘childhood Alzheimer’s’ News article

Autumn Hodgson lives with NP-C, a rare degenerative disease.

ANAVEX®2-73 for mild cognitive impairment or early Alzheimer’s disease Research study

 A clinical trial that aims to assess the safety and efficacy of a new drug (ANAVEX®2-73) for the treatment of early Alzheimer’s disease.

New $33 million Intensive Care Unit opens for critically ill Victorians News article

Victoria’s first comprehensive Intensive Care Unit (ICU) serving three major Melbourne hospitals has opened at the Royal Melbourne Hospital.

Cannabidiol (CBD) as a potential new treatment for mental ill-health in youths Research study

The Cannabidiol for At Risk Youth (CanARY) study is testing a potential new treatment called cannabidiol (CBD) for helping people with symptoms that might indicate risk of a psychotic disorder. CBD is a non-psychoactive treatment, meaning it does not give you a ‘high’.

Respiratory lab and tests

We provide general respiratory services to patients, including respiratory function assessment, fibreoptic bronchoscopy, sleep monitoring, lung oncology and clinical management of all respiratory disorders.

Consumer and carer lived experience workforce

We value the expertise that lived experience brings to our mental health services and are committed to improving our consumer and carer workforce.

Privacy and disclaimer

In accordance with Victorian legislation and Government policy, the Royal Melbourne Hospital protects the privacy of personal and health information it holds. This Privacy Statement explains how your personal information (being information capable of identifying you as an individual) will be...

Barzolvolimab in patients with Chronic Spontaneous Urticaria Research study

This clinical trial seeks to assess the safety and effectiveness of Barzolvolimab in participants with Chronic Spontaneous Urticaria (CSU) who remain symptomatic despite use of antihistamine treatment. 

Centre for Clinical Pastoral Education

Clinical Pastoral Education is an experiential educational process set within the context of direct pastoral ministry.

Our hospital renovation works continue News article

If you’re heading to the RMH Parkville this week, things may look a little different while we renovate our site. Our improvement works have closed certain areas, which may change the path you need to take to get to your floor or ward.

Geographic atrophy from age-related macular degeneration Research study

The Golden trial is a study of a potential new treatment referred to as ISIS 696844 to determine its safety and effectiveness in slowing the progression of geographic atrophy (GA) caused by age-related macular degeneration (AMD).

Chronic Wounds RMH Service

We provide diagnostic and specialist care to people who have wounds that are not healing as expected.

World-first MS research can delay disease progression News article

A new world-first method to help doctors predict which patients are at risk of developing an aggressive form of multiple sclerosis has been uncovered.

TB services for pharmacists

The supply of medications for the treatment of tuberculosis (TB) is managed through the Victorian Tuberculosis Program in conjunction with the Royal Melbourne Hospital (RMH) Pharmacy.

Chronic kidney disease education program

People diagnosed with chronic kidney disease (CKD) are carefully monitored during frequent visits to our specialist clinics and attend the CKD education program to prepare for their future care.

Five years on the road: Mobile Stroke Unit treats more than 2,700 patients News article

The first of its kind to hit the road in Australia, Melbourne’s highly successful Mobile Stroke Unit (MSU) has treated thousands of patients and changed the outcomes of so many Victorians.